Financial Daily from THE HINDU group of publications
Friday, Feb 17, 2006
Financial Daily from THE HINDU group of publications Friday, Feb 17, 2006 |
|
|
|
|
|
|
|
Corporate
-
Events Clinton to visit Cipla Goa unit P.T. Jyothi Datta
New Delhi , Feb. 16 INDIAN companies manufacturing AIDS drugs will see increased activity this week. While the former US President, Mr Bill Clinton, is scheduled to visit Cipla's Goa plant later this week, Bristol Myers Squibb (BMS) has announced a global AIDS-drug related technology-transfer deal with Pune-based drug company Emcure and Aspen, Africa's largest generics manufacturer. Cipla's Joint Managing Director, Mr Amar Lulla, confirmed with Business Line that Mr Clinton would be visiting Cipla's Goa plant on Saturday. Cipla was already supplying anti-retroviral drugs (AIDS medicines) in both the adult and paediatric versions to the Clinton Foundation, he said. The forthcoming visit may help reinforce the existing deal and scale it up, he indicated. In another significant development overseas, BMS has inked an agreement for technology transfer, where there will be a royalty-free licence on the AIDS drug Atazanavir to Emcure and Aspen. Atazanavir, sold by BMS under the brand name Reyataz, is a once-a-day protease inhibitor for AIDS drugs that was approved in the US in mid-2003. While Aspen will sell the product in Africa, the industry representative said that Emcure would be able to manufacture and sell the drug in India. BMS seeks to provide a royalty-free licence and technical know-how related to issues like manufacturing, packaging, storage and the handling of the bulk ingredient and the finished form of the drug. Staff at Emcure and Aspen's manufacturing facilities are also likely to undergo training, the source said. BMS looks at the deal as its commitment to fighting AIDS, the industry representative said.
More Stories on : Events | Pharmaceuticals | Cipla Ltd
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|